Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

186
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

296
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
296
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

291
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
291
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

223
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
223
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

399
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
399
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A rifamycin-free regimen for shortened tuberculosis treatment.

The Lancet. Infectious diseases·2026
Same author

Hydrogel RT-LAMP Enables Rapid, Quantitative Assessment of <i>Mycobacterium tuberculosis</i> Immune Responses.

Analytical chemistry·2026
Same author

Fixed-Dose Rifapentine-Isoniazid (1HP) for Tuberculosis Preventive Treatment in Chinese Adults: A Prospective Real-World Safety and Pharmacokinetic Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Transcriptomic signatures predict severe linezolid-induced peripheral neuropathy and reveal pre-treatment immune and antioxidant dysregulation.

Tuberculosis (Edinburgh, Scotland)·2026
Same author

Durable three-year outcomes and persistent neuropathy following nine-month all-oral regimens for rifampicin-resistant tuberculosis: a multicentre cohort study in China.

BMC infectious diseases·2026
Same author

A catastrophic seven-year course of drug-resistant tuberculosis and lessons for multidisciplinary management: a case report.

BMC infectious diseases·2026

Related Experiment Video

Updated: Aug 7, 2025

Breath Collection from Children for Disease Biomarker Discovery
06:09

Breath Collection from Children for Disease Biomarker Discovery

Published on: February 14, 2019

7.0K

A cross-sectional study: a breathomics based pulmonary tuberculosis detection method.

Liang Fu1, Lei Wang2, Haibo Wang3

  • 1Division Two of the Pulmonary Diseases Department, The Third People's Hospital of Shenzhen, National Clinical Research Center for Infectious Disease, Southern University of Science and Technology, Shenzhen, 518112, China.

BMC Infectious Diseases
|March 10, 2023
PubMed
Summary
This summary is machine-generated.

A novel breathomics method offers a fast, noninvasive way to detect pulmonary tuberculosis (PTB). This approach shows high accuracy and sensitivity, making it a promising tool for PTB screening and diagnosis.

Keywords:
BreathomicsMachine learningPulmonary tuberculosisVolatile organic compounds

More Related Videos

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.8K
Capturing Actively Produced Microbial Volatile Organic Compounds from Human-Associated Samples with Vacuum-Assisted Sorbent Extraction
09:19

Capturing Actively Produced Microbial Volatile Organic Compounds from Human-Associated Samples with Vacuum-Assisted Sorbent Extraction

Published on: June 1, 2022

4.1K

Related Experiment Videos

Last Updated: Aug 7, 2025

Breath Collection from Children for Disease Biomarker Discovery
06:09

Breath Collection from Children for Disease Biomarker Discovery

Published on: February 14, 2019

7.0K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.8K
Capturing Actively Produced Microbial Volatile Organic Compounds from Human-Associated Samples with Vacuum-Assisted Sorbent Extraction
09:19

Capturing Actively Produced Microbial Volatile Organic Compounds from Human-Associated Samples with Vacuum-Assisted Sorbent Extraction

Published on: June 1, 2022

4.1K

Area of Science:

  • Pulmonary Medicine
  • Analytical Chemistry
  • Biomarker Discovery

Background:

  • Current pulmonary tuberculosis (PTB) diagnostics are often inaccurate, costly, or complex.
  • Breathomics presents a potential noninvasive and rapid alternative for PTB detection.

Purpose of the Study:

  • To evaluate the efficacy of a breathomics-based approach for detecting pulmonary tuberculosis (PTB).
  • To assess the performance of machine learning algorithms in analyzing breath volatile organic compounds (VOCs) for PTB diagnosis.

Main Methods:

  • Collected exhaled breath samples from 518 PTB patients and 887 controls.
  • Utilized real-time high-pressure photon ionization time-of-flight mass spectrometry for sample analysis.
  • Applied machine learning algorithms for breathomics analysis and developed a PTB detection model, validated on 430 blinded patients.

Main Results:

  • The breathomics model achieved 92.6% accuracy, 91.7% sensitivity, 93.0% specificity, and an AUC of 0.975 in a blinded test set.
  • Detection performance was not significantly affected by age, sex, or anti-tuberculosis treatment.
  • Distinguishing PTB from other pulmonary diseases yielded 91.2% accuracy, 91.7% sensitivity, 88.0% specificity, and an AUC of 0.961.

Conclusions:

  • A simple, noninvasive breathomics method demonstrates high sensitivity and specificity for PTB detection.
  • This method holds significant potential for clinical PTB screening and diagnosis.